ATE253357T1 - Bergamottin enthaltende zusammensetzungen zur erhöhung der oralen bioverfügbarkeit von pharmazeutika - Google Patents

Bergamottin enthaltende zusammensetzungen zur erhöhung der oralen bioverfügbarkeit von pharmazeutika

Info

Publication number
ATE253357T1
ATE253357T1 AT98939311T AT98939311T ATE253357T1 AT E253357 T1 ATE253357 T1 AT E253357T1 AT 98939311 T AT98939311 T AT 98939311T AT 98939311 T AT98939311 T AT 98939311T AT E253357 T1 ATE253357 T1 AT E253357T1
Authority
AT
Austria
Prior art keywords
bergamottin
oral bioavailability
pharmaceuticals
increasing
compositions containing
Prior art date
Application number
AT98939311T
Other languages
English (en)
Inventor
Kan He
Paul Hollenberg
Thomas F Woolf
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of ATE253357T1 publication Critical patent/ATE253357T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT98939311T 1997-08-19 1998-08-11 Bergamottin enthaltende zusammensetzungen zur erhöhung der oralen bioverfügbarkeit von pharmazeutika ATE253357T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5612997P 1997-08-19 1997-08-19
PCT/US1998/016579 WO1999008676A1 (en) 1997-08-19 1998-08-11 Compositions containing bergamottin for increasing the oral bioavailability of pharmaceutical agents

Publications (1)

Publication Number Publication Date
ATE253357T1 true ATE253357T1 (de) 2003-11-15

Family

ID=22002350

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98939311T ATE253357T1 (de) 1997-08-19 1998-08-11 Bergamottin enthaltende zusammensetzungen zur erhöhung der oralen bioverfügbarkeit von pharmazeutika

Country Status (15)

Country Link
US (1) US6509371B1 (de)
EP (1) EP1007034B1 (de)
JP (1) JP2001515035A (de)
KR (1) KR100510809B1 (de)
AT (1) ATE253357T1 (de)
AU (1) AU747051B2 (de)
BR (1) BR9812131A (de)
CA (1) CA2291233C (de)
DE (1) DE69819519T2 (de)
DK (1) DK1007034T3 (de)
ES (1) ES2209184T3 (de)
NZ (1) NZ502668A (de)
PT (1) PT1007034E (de)
WO (1) WO1999008676A1 (de)
ZA (1) ZA987436B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1014575A3 (fr) * 2002-01-16 2004-01-13 Chapelle Andre Composition a base de 5,7 dmc et/ou de bergamottine.
US7169763B2 (en) * 2002-02-22 2007-01-30 Oliver Yoa-Pu Hu Cytochrome P450 3A inhibitors and enhancers
US8257755B2 (en) 2005-01-21 2012-09-04 Arkray, Inc. Metabolic syndrome-improving agent and medicine, supplement, functional food and food additive containing the same
JP4902964B2 (ja) * 2005-03-30 2012-03-21 株式会社ファンケル 薬物の代謝阻害剤とその使用
WO2014191569A1 (en) 2013-05-30 2014-12-04 Nanobiotix Pharmaceutical composition, preparation and uses thereof
EP3229776B1 (de) 2014-11-25 2023-06-28 Curadigm Sas Pharmazeutische zusammensetzung mit kombination von mindestens zwei verschiedenen nanoteilchen und pharmazeutische zusammensetzung, herstellung und verwendungen
EP3223796B1 (de) * 2014-11-25 2021-07-21 Curadigm Sas Pharmazeutische zusammensetzung, herstellung und verwendungen davon
KR101729494B1 (ko) 2015-06-29 2017-04-25 제주대학교 산학협력단 6,7-디하이드록시 베르가모틴을 함유한 화장료 조성물
WO2024223797A1 (en) 2023-04-28 2024-10-31 Institut National de la Santé et de la Recherche Médicale Use of cyp3a4 inhibitors for the treatment of hepatitis d virus (hdv) infections

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2996838B2 (ja) * 1993-07-12 2000-01-11 株式会社ポッカコーポレーション 抗菌剤
US5567592A (en) 1994-02-02 1996-10-22 Regents Of The University Of California Screening method for the identification of bioenhancers through the inhibition of P-glycoprotein transport in the gut of a mammal
CA2224227A1 (en) 1995-06-07 1996-12-19 Avmax, Inc. Use of essential oils to increase bioavailability of oral pharmaceutical compounds
US5665386A (en) 1995-06-07 1997-09-09 Avmax, Inc. Use of essential oils to increase bioavailability of oral pharmaceutical compounds
US5716928A (en) 1995-06-07 1998-02-10 Avmax, Inc. Use of essential oils to increase bioavailability of oral pharmaceutical compounds
US6160006A (en) * 1996-10-18 2000-12-12 Wayne State University 6',7'-dihydroxybergamottin, a cytochrome P450 inhibitor in grapefruit

Also Published As

Publication number Publication date
KR20010023034A (ko) 2001-03-26
BR9812131A (pt) 2000-07-18
DE69819519T2 (de) 2004-09-23
NZ502668A (en) 2001-10-26
WO1999008676A1 (en) 1999-02-25
US6509371B1 (en) 2003-01-21
JP2001515035A (ja) 2001-09-18
ZA987436B (en) 1999-02-22
KR100510809B1 (ko) 2005-08-31
AU747051B2 (en) 2002-05-09
CA2291233C (en) 2006-10-10
ES2209184T3 (es) 2004-06-16
EP1007034B1 (de) 2003-11-05
AU8777098A (en) 1999-03-08
DE69819519D1 (de) 2003-12-11
CA2291233A1 (en) 1999-02-25
EP1007034A1 (de) 2000-06-14
DK1007034T3 (da) 2004-03-22
PT1007034E (pt) 2004-03-31

Similar Documents

Publication Publication Date Title
WO2001090091A8 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
ATE218341T1 (de) Zwischenverbindungen von fortgeschrittenen glykosylierung-endprodukten und post-amadorische inhibitor
IT1312377B1 (it) Composizioni a base di acido tiottico, cisteina e/o n-acetil cisteinada utilizzarsi in preparazioni farmaceutiche, dietetiche e cosmetiche
AU2002231544A1 (en) Therapeutic uses of herbal compositions
MXPA01013210A (es) Composiciones farmaceuticas y nutricionales que contienen acidos grasos esenciales y agentes que disminuyen en la homocisteina.
YU57600A (sh) Derivarti biciklične hidroksaminske kiseline
GEP20053602B (en) Aripiprazole for Oral Administration
HUP0201214A3 (en) Inhibitors of impdh enzyme, pharmaceutical compositions containing them and their use
HUP0000838A2 (hu) Szteroid-glikozidot tartalmazó extraktum, eljárás izolálására és szintetikus előállítására, valamint ezt tartalmazó étvágycsökkentő gyógyszerkészítmények
BR0108564A (pt) Preparações cosméticas contendo extratos vegetais
ATE253357T1 (de) Bergamottin enthaltende zusammensetzungen zur erhöhung der oralen bioverfügbarkeit von pharmazeutika
FR2827774B1 (fr) Preparations pharmaceutiques et/ou dietetiques contenant un extrait vegetal titre en composes actifs et des micro-organismes probiotiques
AU2003246567A1 (en) Administration form for the oral administration of active substances, vitamins, and/or nutrients
AU2030497A (en) Propynyl or dienyl biaromatic compounds
MY130792A (en) 17ß-HYDROXYSTEROID DEHYDROGENASE TYPE 3 INHIBITORS FOR THE TREATMENT OF ANDROGEN DEPENDENT DISEASES
NO992998L (no) Nye analoger av camptotecin, anvendelse som medikamenter og farmasöytiske blandinger som inneholder disse
AU5634500A (en) Dietary calcium as a supplement to vitamin d compound treatment of multiple sclerosis
AU2003246566A1 (en) Administration form for the oral administration of active substances, vitamins, and/or nutrients
WO2001024803A3 (en) Pharmaceutical compositions containing copper, salicylic acid and vitamines c
HK1045987A1 (zh) 3-氨基-2-苄基-1-苯基-丙烷衍生物
RU94031068A (ru) Биологически активная добавка для косметических средств
HUP9902421A2 (hu) Nyálkahártya-viszkozitást optimalizáló és bélfunkciót stimuláló hatású készítmények
WO2002070069A3 (fr) Utilisation d'un ou plusieurs shogaol(s) en tant qu'aphrodisiaque
EP1491192A4 (de) Die biologische wirkung fördernde zusammensetzungen mit isoflavon-agklykon aus sojabohnenkeimen
ATE301469T1 (de) Pharmazeutische diclofenac-verbindung basierend auf vitamin e, papain und hyaluronidase

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1007034

Country of ref document: EP

REN Ceased due to non-payment of the annual fee